Skip to content
healthcare.dev

Spironolactone and Hydrochlorothiazide

NDC 42292-017, spironolactone and hydrochlorothiazide, tablet, from Mylan Institutional Inc..

Product NDC
42292-017
Status
Listed
Labeler
Mylan Institutional Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA086513
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42292-017 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SPIRONOLACTONE25 mg/1
  • HYDROCHLOROTHIAZIDE25 mg/1

Pharmacologic classes

Aldosterone Antagonist [EPC]; Aldosterone Antagonists [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
42292-017-2042292001720100 BLISTER PACK in 1 CARTON (42292-017-20) / 1 TABLET in 1 BLISTER PACK (42292-017-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f2a4fbc0-650b-440d-9555-c1720fe0fe35
  • NADAC price for package 42292001720

    GET /v1/drugs/nadac/42292001720

Use it

Look up 42292-017 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42292-017 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42292-017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.